Thomas Scheeren
@scheerenthomas
ID: 1305759747463839744
15-09-2020 06:46:17
15 Tweet
51 Followers
32 Following
Research agenda for the coming years from international experts. Indications, current practice, and therapeutic goals of inotrope therapy in the treatment of patients with circulatory shock. Rupert Pearse pubmed.ncbi.nlm.nih.gov/33512597/
#AIC #OpenAccess Scheeren et al - #Inotrope therapy in #circulatory_shock: an International survey bit.ly/3rd1vf6 #FOAMEd #FOAMcc #ICU #Levosimendan #Catecholamines #Sepsis #Resuscitation #circulatory_failure #cardiac_output Thomas Scheeren
📅 Organised by ESICM's Cardiovascular Dynamics Section, this webinar will review the latest guidelines on predicting #fluid response & fluid doses in patients with #SepticShock. Anders Perner Thomas Scheeren Adrian Wong M Velia Antonini #IntensiveCare loom.ly/WgOk7pQ
🎥 Join today's webinar & review the latest guidelines on predicting #fluid response & fluid doses in patients with #SepticShock. Connect & interact with our expert panel 👉 mailchi.mp/c66ed287fe02/c… Anders Perner Thomas Scheeren Adrian Wong M Velia Antonini #IntensiveCare
From Jonathan Montomoli, Matthias Hilty, Bernd Saugel, Thomas Scheeren, et al comes the featured #haemodynamics article. The first clinical study which tested a new parameter for #microcirculation monitoring #tissueRedBloodCellPerfusion. Read here: bit.ly/3bFBhQ7
We are happy to share that Prof. Dr. Thomas Scheeren has joined Edwards Lifesciences Europe as Medical Affairs Sr. Director CCVas. His contribution will enhance our engagement to improve #PatientSafety - a growing public health challenge - in the perioperative pathway.